Monash IVF Group Limited
ASX:MVF.AX
0.835 (AUD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 254.96 | 213.59 | 192.294 | 183.605 | 145.417 | 151.98 | 150.638 | 155.182 | 156.561 | 124.955 | 114.012 | 96.598 |
| Cost of Revenue
| 169.46 | 150.18 | 135.073 | 125.948 | 107.047 | 99.128 | 90.697 | 86.757 | 87.177 | 72.361 | 64.049 | 53.884 |
| Gross Profit
| 85.5 | 63.41 | 57.221 | 57.657 | 38.37 | 52.852 | 59.941 | 68.425 | 69.384 | 52.594 | 49.963 | 42.714 |
| Gross Profit Ratio
| 0.335 | 0.297 | 0.298 | 0.314 | 0.264 | 0.348 | 0.398 | 0.441 | 0.443 | 0.421 | 0.438 | 0.442 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 88.823 | 11.289 | 11.973 | 7.993 | 6.572 | 6.017 | 5.824 | 5.355 | 5.592 | 4.546 | 5.07 | 4.384 |
| Selling & Marketing Expenses
| 7.716 | 6.92 | 6.434 | 6.387 | 5.718 | 4.989 | 4.033 | 4.718 | 4.534 | 4.215 | 3.531 | 1.97 |
| SG&A
| 96.539 | 28.373 | 26.315 | 22.54 | 21.437 | 11.006 | 16.925 | 16.245 | 16.085 | 8.761 | 8.601 | 6.354 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | -1.355 | 0 | 0 | 0 | 0.574 | -12.281 | 0 |
| Operating Expenses
| 91.109 | 28.373 | 26.315 | 22.54 | 21.437 | 21.565 | 26.907 | 23.973 | 24.564 | 17.537 | 31.763 | 11.199 |
| Operating Income
| -5.609 | 35.037 | 30.906 | 35.117 | 16.933 | 32.742 | 33.158 | 44.613 | 45.37 | 37.895 | 35.948 | 30.687 |
| Operating Income Ratio
| -0.022 | 0.164 | 0.161 | 0.191 | 0.116 | 0.215 | 0.22 | 0.287 | 0.29 | 0.303 | 0.315 | 0.318 |
| Total Other Income Expenses Net
| -5.047 | -3.279 | -4.684 | -2.451 | -5.707 | -5.157 | -3.553 | -3.46 | -4.773 | -4.726 | -37.863 | -32.99 |
| Income Before Tax
| -10.656 | 29.839 | 26.222 | 36.2 | 16.126 | 27.485 | 29.605 | 41.153 | 40.597 | 30.701 | -1.915 | -2.303 |
| Income Before Tax Ratio
| -0.042 | 0.14 | 0.136 | 0.197 | 0.111 | 0.181 | 0.197 | 0.265 | 0.259 | 0.246 | -0.017 | -0.024 |
| Income Tax Expense
| -4.707 | 7.873 | 7.72 | 10.513 | 4.366 | 7.678 | 8.424 | 11.534 | 11.822 | 9.328 | 6.767 | 10.422 |
| Net Income
| -6.527 | 21.839 | 18.406 | 25.148 | 11.726 | 19.852 | 21.353 | 29.619 | 28.775 | 21.373 | 2.581 | -14.856 |
| Net Income Ratio
| -0.026 | 0.102 | 0.096 | 0.137 | 0.081 | 0.131 | 0.142 | 0.191 | 0.184 | 0.171 | 0.023 | -0.154 |
| EPS
| -0.017 | 0.056 | 0.047 | 0.065 | 0.046 | 0.061 | 0.065 | 0.13 | 0.12 | 0.092 | 0.021 | -0.3 |
| EPS Diluted
| -0.017 | 0.056 | 0.047 | 0.065 | 0.045 | 0.061 | 0.065 | 0.12 | 0.12 | 0.092 | 0.02 | -0.3 |
| EBITDA
| 13.025 | 48.486 | 45.694 | 51.209 | 32.844 | 36.454 | 38.118 | 48.987 | 49.61 | 40.962 | 38.353 | 34.075 |
| EBITDA Ratio
| 0.051 | 0.227 | 0.238 | 0.279 | 0.226 | 0.24 | 0.253 | 0.316 | 0.317 | 0.328 | 0.336 | 0.353 |